(Q39586226)

13 September 2017

title

Fibroblast growth factor-2 enhances NK sensitivity of hepatocellular carcinoma cells (English)

1 reference

13 September 2017

main subject

hepatocellular carcinoma

1 reference

11

Tetsuo Takehara

1 reference

13 September 2017

8

Naoki Hiramatsu

1 reference

13 September 2017

2

Tomohide Tatsumi

1 reference

13 September 2017

6

Takuya Miyagi

1 reference

13 September 2017

Hinako Tsunematsu

1

1 reference

13 September 2017

Keisuke Kohga

3

1 reference

13 September 2017

Masashi Yamamoto

4

1 reference

13 September 2017

Hiroshi Aketa

5

1 reference

13 September 2017

Atsushi Hosui

7

1 reference

13 September 2017

Tatsuya Kanto

9

1 reference

13 September 2017

Norio Hayashi

10

1 reference

13 September 2017

language of work or name

English

0 references

publication date

25 April 2011

1 reference

International Journal of Cancer

13 September 2017

published in

1 reference

13 September 2017

volume

130

1 reference

13 September 2017

issue

2

1 reference

13 September 2017

page(s)

356-364

1 reference

Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma

13 September 2017

cites work

1 reference

Altered expression of vascular endothelial growth factor, fibroblast growth factor-2 and endostatin in patients with hepatocellular carcinoma.

21 January 2018

1 reference

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

21 January 2018

1 reference

Primary liver cancer: worldwide incidence and trends

21 January 2018

1 reference

Innate and adaptive lymphoid cells in the human liver

21 January 2018

1 reference

Immunology of the healthy liver: old questions and new insights

21 January 2018

1 reference

NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy

21 January 2018

1 reference

Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma

21 January 2018

1 reference

Fas / FasL system, IL-1beta expression and apoptosis in chronic HBV and HCV liver disease.

21 January 2018

1 reference

Serum levels of interleukin-6 and its soluble receptors in patients with hepatitis C virus infection

21 January 2018

1 reference

Plasma level of basic fibroblast growth factor increases with progression of chronic liver disease.

21 January 2018

1 reference

Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma

21 January 2018

1 reference

Interleukin-6 induced basic fibroblast growth factor-dependent angiogenesis in basal cell carcinoma cell line via JAK/STAT3 and PI3-kinase/Akt pathways.

21 January 2018

1 reference

Inflammatory cytokines induce the expression of basic fibroblast growth factor (bFGF) isoforms required for the growth of Kaposi's sarcoma and endothelial cells through the activation of AP-1 response elements in the bFGF promoter.

21 January 2018

1 reference

Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid

21 January 2018

1 reference

Sorafenib inhibits the shedding of major histocompatibility complex class I-related chain A on hepatocellular carcinoma cells by down-regulating a disintegrin and metalloproteinase 9.

21 January 2018

1 reference

Effect of NKG2D ligand expression on host immune responses

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.26003

1 reference

release_xsuymwj4ozfcrff7ebiuuo5o5u

13 September 2017

Fatcat ID

0 references

1 reference